Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway

[1]  M. Soleimani,et al.  Survival Improvement in Human Retinal Pigment Epithelial Cells via Fas Receptor Targeting by miR‐374a , 2017, Journal of cellular biochemistry.

[2]  Q. Zhen,et al.  LncRNA GHET1 Promotes Esophageal Squamous Cell Carcinoma Cells Proliferation and Invasion via Induction of EMT , 2017, The International journal of biological markers.

[3]  Yongchao Li,et al.  TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis. , 2017, Biochemical and biophysical research communications.

[4]  Mengtao Zhou,et al.  The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382 , 2017, Cellular Physiology and Biochemistry.

[5]  J. Kang,et al.  Promotion of LncRNA HOXA11-AS on the proliferation of hepatocellular carcinoma by regulating the expression of LATS1. , 2017, European Review for Medical and Pharmacological Sciences.

[6]  Han Wu,et al.  Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p , 2017, Molecular Cancer.

[7]  Han Wu,et al.  Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p , 2017, Molecular cancer.

[8]  Yafeng Song,et al.  Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway , 2017, Oncotarget.

[9]  Suinuan Wang,et al.  Long non-coding RNA in glioma: signaling pathways , 2017, Oncotarget.

[10]  Y. Hua,et al.  Long non-coding RNAs in osteosarcoma , 2017, Oncotarget.

[11]  Yingying Hu,et al.  Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration , 2017, Cancer medicine.

[12]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[13]  Xiaonan Li,et al.  HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2 , 2016, Scientific Reports.

[14]  A. Chinnaiyan,et al.  The bright side of dark matter: lncRNAs in cancer. , 2016, The Journal of clinical investigation.

[15]  S. Lakhani,et al.  Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer , 2016, Human molecular genetics.

[16]  Yan Zhang,et al.  MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42. , 2016, Biochemical and biophysical research communications.

[17]  J. Dou,et al.  Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells. , 2016, American journal of translational research.

[18]  Zhijin Zhang,et al.  LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability and promotes apoptosis of colorectal cancer cells. , 2016, American journal of translational research.

[19]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[20]  Maite Huarte.  The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[21]  Ping Wang,et al.  Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326 , 2015, Oncotarget.

[22]  Massimo Negrini,et al.  Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR , 2015, Biomarker Research.

[23]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[24]  Shaohua Chen,et al.  Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells , 2014, BMC Cancer.

[25]  Yangchao Chen,et al.  Targeting long non-coding RNAs in cancers: progress and prospects. , 2013, The international journal of biochemistry & cell biology.

[26]  J. Mattick,et al.  Structure and function of long noncoding RNAs in epigenetic regulation , 2013, Nature Structural &Molecular Biology.

[27]  Xiang Du,et al.  The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine , 2013, Modern Pathology.

[28]  I. Jatoi,et al.  The global breast cancer burden. , 2012, Future oncology.

[29]  P. Lambin,et al.  Radiation-induced oesophagitis in lung cancer patients , 2012, Strahlentherapie und Onkologie.

[30]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[31]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[32]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[33]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[34]  J. Hugosson,et al.  Radical retropubic prostatectomy: A review of outcomes and side-effects , 2011, Acta oncologica.

[35]  P. Fraser,et al.  No-Nonsense Functions for Long Noncoding RNAs , 2011, Cell.

[36]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[37]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[38]  Dino Amadori,et al.  The global breast cancer burden: variations in epidemiology and survival. , 2005, Clinical breast cancer.

[39]  N. Myong.  Tissue Microarray Analysis of Fas and FasL Expressions in Human Non-small Cell Lung Carcinomas; with Reference to the p53 and bcl-2 Overexpressions , 2005, Journal of Korean medical science.

[40]  L. Chiang,et al.  Upregulation of Fas/Fas ligand‐mediated apoptosis by gossypol in an immortalized human alveolar lung cancer cell line , 2004, Clinical and experimental pharmacology & physiology.

[41]  T. Key,et al.  Epidemiology of breast cancer. , 2001, The Lancet. Oncology.